Literature DB >> 7196546

Amitriptyline-induced ophthalmoplegia.

R H Spector, R Schnapper.   

Abstract

Total external ophthalmoplegia, unresponsive to caloric stimulation, was observed in a gravid woman who had ingested approximately 1.0 to 1.5 gm of amitriptyline. The intravenous administration of 4.0 mg physostigmine salicylate (PS) produced a revival of consciousness and reflex activity but had no appreciable effect on ocular motility. A prior case report of amitriptyline-induced ophthalmoplegia in a patient who took lesser amounts of the medication described immediate restoration of eye movement with only 2 mg of intravenous PS. The action of the amitriptyline on the vestibuloocular reflex seems to involve cholinergic transmission and the effect of the drug may be dose related.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7196546     DOI: 10.1212/wnl.31.9.1188

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  6 in total

1.  Full neurological recovery following tricyclic overdose associated with absent brainstem reflexes.

Authors:  Deborah Webster; Priya Datar; Sam Waddy
Journal:  J Intensive Care Soc       Date:  2018-03-22

2.  Overdose of tricyclic antidepressants associated with absent brain-stem reflexes.

Authors:  A White
Journal:  CMAJ       Date:  1988-07-15       Impact factor: 8.262

3.  Acute amitriptyline withdrawal and hyponatraemia. A case report.

Authors:  P Davison; J Wardrope
Journal:  Drug Saf       Date:  1993-01       Impact factor: 5.606

Review 4.  Drug-induced neurological disorders.

Authors:  R J Lane; P A Routledge
Journal:  Drugs       Date:  1983-08       Impact factor: 9.546

5.  Neuroleptic malignant syndrome.

Authors:  A V Srinivasan; M Murugappan; S G Krishnamurthy; Z A Sayeed
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-06       Impact factor: 10.154

Review 6.  Toxicologic Confounders of Brain Death Determination: A Narrative Review.

Authors:  Lauren Murphy; Hannah Wolfer; Robert G Hendrickson
Journal:  Neurocrit Care       Date:  2020-09-30       Impact factor: 3.532

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.